These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 23658482

  • 21. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP, Quan DP, Liao KR, Tao Wang, Peng Xiang, Mai KC.
    J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
    [Abstract] [Full Text] [Related]

  • 22. Chitosan Coating Effect on Cellular Uptake of PLGA Nanoparticles for Boron Neutron Capture Therapy.
    Takeuchi I, Ariyama M, Makino K.
    J Oleo Sci; 2019 Apr 01; 68(4):361-368. PubMed ID: 30867387
    [Abstract] [Full Text] [Related]

  • 23. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
    Salama AH, Mahmoud AA, Kamel R.
    AAPS PharmSciTech; 2016 Oct 01; 17(5):1159-72. PubMed ID: 26589410
    [Abstract] [Full Text] [Related]

  • 24. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M, Rong WT, Hou J, Wang DF, Lu Y, Wang Y, Yu SQ, Xu Q.
    Nanotechnology; 2013 Jun 21; 24(24):245101. PubMed ID: 23702815
    [Abstract] [Full Text] [Related]

  • 25. Preparation, characterization and uptake of PEG-coated, muco-inert nanoparticles in HGC-27 cells, a mucin-producing, gastric-cancer cell line.
    Lin D, Li G, Qin L, Wen Z, Wang J, Sun X.
    J Biomed Nanotechnol; 2013 Dec 21; 9(12):2017-23. PubMed ID: 24266257
    [Abstract] [Full Text] [Related]

  • 26. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L, Hou L, Guo D, Xiao X, Mao P, Yang X.
    Int J Pharm; 2012 Oct 15; 436(1-2):815-24. PubMed ID: 22846410
    [Abstract] [Full Text] [Related]

  • 27. Levofloxacin loaded chitosan and poly-lactic-co-glycolic acid nano-particles against resistant bacteria: Synthesis, characterization and antibacterial activity.
    Hayee R, Iqtedar M, Albekairi NA, Alshammari A, Makhdoom MA, Islam M, Ahmed N, Rasool MF, Li C, Saeed H.
    J Infect Public Health; 2024 May 15; 17(5):906-917. PubMed ID: 38569270
    [Abstract] [Full Text] [Related]

  • 28. Preparation and in-vitro/in-vivo evaluation of surface-modified poly (lactide-co-glycolide) fluorescent nanoparticles.
    Pamujula S, Hazari S, Bolden G, Graves RA, Chinta DM, Dash S, Kishore V, Mandal TK.
    J Pharm Pharmacol; 2010 Apr 15; 62(4):422-9. PubMed ID: 20604830
    [Abstract] [Full Text] [Related]

  • 29. Chitosan-Coated Poly(lactic-co-glycolic acid)-Diiodinated boron-Dipyrromethene Nanoparticles Improve Tumor Selectivity and Stealth Properties in Photodynamic Cancer Therapy.
    Voon SH, Tiew SX, Kue CS, Lee HB, Kiew LV, Misran M, Kamkaew A, Burgess K, Chung LY.
    J Biomed Nanotechnol; 2016 Jul 15; 12(7):1431-52. PubMed ID: 29336539
    [Abstract] [Full Text] [Related]

  • 30. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
    Nair K L, Jagadeeshan S, Nair SA, Kumar GS.
    Int J Nanomedicine; 2011 Jul 15; 6():1685-97. PubMed ID: 21980233
    [Abstract] [Full Text] [Related]

  • 31. Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery.
    Asal HA, Shoueir KR, El-Hagrasy MA, Toson EA.
    Int J Biol Macromol; 2022 Jun 01; 209(Pt B):2188-2196. PubMed ID: 35504421
    [Abstract] [Full Text] [Related]

  • 32. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs.
    Takeuchi I, Takeshita T, Suzuki T, Makino K.
    Colloids Surf B Biointerfaces; 2017 Dec 01; 160():520-526. PubMed ID: 29017147
    [Abstract] [Full Text] [Related]

  • 33. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations.
    Tariq M, Alam MA, Singh AT, Iqbal Z, Panda AK, Talegaonkar S.
    Colloids Surf B Biointerfaces; 2015 Apr 01; 128():448-456. PubMed ID: 25769281
    [Abstract] [Full Text] [Related]

  • 34. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
    Jose S, Juna BC, Cinu TA, Jyoti H, Aleykutty NA.
    Colloids Surf B Biointerfaces; 2016 Jun 01; 142():307-314. PubMed ID: 26970818
    [Abstract] [Full Text] [Related]

  • 35. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.
    Pandit J, Sultana Y, Aqil M.
    Artif Cells Nanomed Biotechnol; 2017 Nov 01; 45(7):1397-1407. PubMed ID: 27855494
    [Abstract] [Full Text] [Related]

  • 36. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
    Chung YI, Kim JC, Kim YH, Tae G, Lee SY, Kim K, Kwon IC.
    J Control Release; 2010 May 10; 143(3):374-82. PubMed ID: 20109508
    [Abstract] [Full Text] [Related]

  • 37. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q, Wang A, Hua H, Jiang Y, Wang Y, Mu H, Wu Z, Sun K.
    Int J Nanomedicine; 2018 May 10; 13():705-718. PubMed ID: 29440896
    [Abstract] [Full Text] [Related]

  • 38. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.
    Katas H, Chen S, Osamuyimen AA, Cevher E, Oya Alpar H.
    J Microencapsul; 2008 Dec 10; 25(8):541-8. PubMed ID: 18465303
    [Abstract] [Full Text] [Related]

  • 39. Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine.
    Zhao K, Zhang Y, Zhang X, Shi C, Wang X, Wang X, Jin Z, Cui S.
    Int J Nanomedicine; 2014 Dec 10; 9():4609-19. PubMed ID: 25356070
    [Abstract] [Full Text] [Related]

  • 40. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
    Ignjatović NL, Penov-Gaši KM, Wu VM, Ajduković JJ, Kojić VV, Vasiljević-Radović D, Kuzmanović M, Uskoković V, Uskoković DP.
    Colloids Surf B Biointerfaces; 2016 Dec 01; 148():629-639. PubMed ID: 27694053
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.